I-Pomalidomide

Incazelo emfushane:

Igama le-API Inkomba Umsunguli Idethi yokuphelelwa yisikhathi kwelungelo lobunikazi(e-US)
I-Pomalidomide Umuthi we-Oncology Celgene  

 


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

I-Pomalidomide, phambilini eyayaziwa ngokuthi i-CC-4047 noma i-actimid, iyingqamuzana enamandla yokuzivikela komzimba ebonisa umsebenzi we-antineoplastic ekwelapheni izifo eziphathelene ne-hematological, ikakhulukazi i-multiple myeloma (MM) ephinde yabuyela emuva kanye ne-refractory. Njengokuphuma ku-thalidomide, i-pomalidomide inokwakheka kwamakhemikhali okufanayo njenge-thalidomide ngaphandle kokwengezwa kwamaqembu e-oxo amabili eringini ye-phthaloyl kanye neqembu le-amino endaweni yesine. Ngokuvamile, njenge-molecule ye-immunomodulatory, i-pomalidomide ibonisa umsebenzi we-antitumor ngokusebenzisa indlela yokuvimbela i-tumor microenvironment ngokushintshanisa ama-cytokines asekela isimila (TNF-α, IL-6, IL-8 kanye ne-VEGF), eqondisa ngokuqondile imisebenzi ebalulekile yesimila. amaseli, nosekelo olubandakanyayo oluvela kumaseli angawona amasosha omzimba.

I-Pomalidomide isetshenziselwa ukwelapha i-myeloma eminingi (umdlavuza obangelwa isifo segazi esiqhubekayo). I-pomalidomide ivamise ukunikezwa ngemva kokuthi kuzanywe okungenani eminye imithi emibili ngaphandle kwempumelelo.

I-pomalidomide iphinde isetshenziselwe ukwelapha i-Kaposi sarcoma ehlobene nengculazi lapho eminye imithi ingasebenzi noma iyekile ukusebenza. I-pomalidomide ingasetshenziswa futhi ukwelapha i-Kaposi Sarcoma kubantu abadalaI-HIV-negative.

I-pomalidomide itholakala kuphela ekhemisi eliqinisekisiwe ngaphansi kohlelo olukhethekile. Kufanele ubhalise ohlelweni futhi uvume ukusebenzisaukulawula inzaloizinyathelo njengoba kudingeka.

I-pomalidomide ingase isetshenziselwe izinjongo ezingabaliwe kulo mhlahlandlela wemithi.

I-pomalidomide ingabangela ukukhubazeka okunzima, okusongela ukuphila noma ukufa kwengane uma umama noma ubaba ethatha i-pomalidomide ngesikhathi sokukhulelwa noma ngesikhathi sokukhulelwa. Ngisho nomthamo owodwa we-pomalidomide ungabangela ukukhubazeka okukhulu ezingalweni nemilenze yomntwana, amathambo, izindlebe, amehlo, ubuso nenhliziyo. Ungalokothi usebenzise i-pomalidomide uma ukhulelwe. Tshela udokotela wakho ngokushesha uma isikhathi sakho sekwephuzile ngenkathi uthatha i-pomalidomide.

ISItifiketi

2018 GMP-2
原料药GMP证书201811 (captopril,thalidomide njll)
I-GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
I-FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Ukuphathwa kwekhwalithi1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Ukuphathwa kwekhwalithi2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Ukuphathwa kwekhwalithi3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Ukuphathwa kwekhwalithi4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
Ukubambisana kwamazwe ngamazwe
Ukubambisana kwasekhaya
Ukubambisana kwasekhaya

  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona